Winquist E, Hotte SJ, Chi K, Sridhar S, et al. Randomized Phase II Study of Durvalumab with or without Tremelimumab in Patients with Metastatic Castration Resistant Prostate Cancer. Clin Cancer Res 2024 Nov 8. doi: 10.1158/1078-0432.CCR-24-1612.
PMID: 39513948